IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Amyris narrows loss

3:16 PM MDT | August 7, 2014 | Rebecca Coons

Biobased farnesene firm Amyris (Emeryville, CO) reports a second-quarter net loss of $35.5 million, compared to a net loss of $38.9 million in the year-ago quarter. Sales slipped 14.2%, to $9.3 million. Renewable product sales revenue was $4.4 million, a 5.4% increase over the second quarter of 2013.    Recognized grants and collaborations revenues were $4.9 million on a GAAP basis. Expanded isoprene collaboration with addition of a new partner, Braskem, and added first cosmetic product collaboration with Natura, BioAmber says. "With two new...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa